

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>HL7.EU.FHIR.GH\cfsb1639004037108 - TTL Representation - FHIR v5.0.0-snapshot1</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
    <link href="assets/css/pcsp.css" rel="stylesheet"/>

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>

    <style type="text/css">h2{--heading-prefix:"8.52"}
    h3,h4,h5,h6{--heading-prefix:"8.52"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->
        
        <div id="hl7-nav">
          <a id="hl7-logo" no-external="true" href="https://www.gravitatehealth.eu/">
            <img height="60" alt="Visit the Project website" src="assets/images/logo-header.jpg"/>
          </a>
        </div>
 <!--        <div id="family-nav">
          <a id="family-logo" no-external="true" href="https://www.pancare.eu/projects"><img height="40" alt="Visit the PanCareSurPass website" src="assets/images/who-logo-www.jpg"/> </a>
        </div> -->
        <div id="hl7-search">
          <a id="hl7-search-lnk" no-external="true" href="http://hl7.org/fhir/search.cfm"><img alt="Search FHIR" src="assets/images/search.png"/></a>
        </div>


        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">Gravitate Health FHIR Implementation Guide</span><br/>0.1.0 - CI Build</p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://build.fhir.org/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <!-- menu.xml  -->

<ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <li>
    <a href="index.html">IG Home</a>
  </li>
  <li>
    <a href="toc.html">Table of Contents</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Contextual information
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="connections.html">Connections</a>
      </li>
      <li>
        <a href="ePI-structure.html">ePI structure</a>
      </li>
      <li>
        <a href="use-case-example.html">Use Case</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Capability Statements
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="CapabilityStatement-capability-statement-ema.html">SmPC / PL</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="artifacts.html">Artifact Index</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Support
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="http://hl7.org/fhir/R4/index.html">FHIR Spec</a>
      </li>
      <li>
        <a href="downloads.html">Downloads</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="copyright.html">Copyright</a>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>cfsb1639004037108</b></li>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div style="counter-reset: section 9" class="col-12">
<!--ReleaseHeader--><p id="publish-box">Gravitate Health FHIR Implementation Guide - Local Development build (v0.1.0). See the <a href="http://hl7.eu/fhir/ig/gravitate-health/history.html">Directory of published versions</a></p><!--EndReleaseHeader-->







<ul class="nav nav-tabs">

  <li>
    <a href="Composition-cfsb1639004037108.html">Narrative Content</a>
  </li>


  
    <li>
      <a href="Composition-cfsb1639004037108.xml.html">XML</a>
    </li>
  


  
    <li>
      <a href="Composition-cfsb1639004037108.json.html">JSON</a>
    </li>
  


  
    <li class="active">
      <a href="#">TTL</a>
    </li>
  



</ul>


<a name="root"> </a>


<h2 id="root">: cfsb1639004037108 - TTL Representation</h2>

<p><a href="Composition-cfsb1639004037108.ttl" no-download="true">Raw ttl</a> | <a href="Composition-cfsb1639004037108.ttl" download>Download</a></p>

  <!-- insert intro if present -->
  



  <pre class="rdf"><code class="language-turtle">
@prefix fhir: &lt;http://hl7.org/fhir/&gt; .
@prefix owl: &lt;http://www.w3.org/2002/07/owl#&gt; .
@prefix rdfs: &lt;http://www.w3.org/2000/01/rdf-schema#&gt; .
@prefix xsd: &lt;http://www.w3.org/2001/XMLSchema#&gt; .

# - resource -------------------------------------------------------------------

 a fhir:Composition;
  <a href="http://build.fhir.org/rdf.html#tree-root">fhir:nodeRole</a> fhir:treeRoot;
  <a href="http://build.fhir.org/composition.html#Composition.id">fhir:Resource.id</a> [ <a href="http://build.fhir.org/datatypes.html#id">fhir:value</a> &quot;cfsb1639004037108&quot;];
  <a href="http://build.fhir.org/composition.html#Composition.language">fhir:Resource.language</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;en&quot;];
  <a href="http://build.fhir.org/composition.html#Composition.text">fhir:DomainResource.text</a> [
     <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;generated&quot; ];
     fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot; xml:lang=\&quot;en\&quot; lang=\&quot;en\&quot;&gt;&lt;p&gt;&lt;b&gt;Generated Narrative&lt;/b&gt;&lt;/p&gt;&lt;div style=\&quot;display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\&quot;&gt;&lt;p style=\&quot;margin-bottom: 0px\&quot;&gt;Resource \&quot;cfsb1639004037108\&quot;  (Language \&quot;en\&quot;) &lt;/p&gt;&lt;/div&gt;&lt;p&gt;&lt;b&gt;status&lt;/b&gt;: final&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: Package Leaflet &lt;span style=\&quot;background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\&quot;&gt; (#100000155538)&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;date&lt;/b&gt;: 2015-02-07T13:28:17Z&lt;/p&gt;&lt;p&gt;&lt;b&gt;author&lt;/b&gt;: &lt;a href=\&quot;Organization-cfsb1639003145277.html\&quot;&gt;Organization/cfsb1639003145277&lt;/a&gt; \&quot;Almirall S.A.\&quot;&lt;/p&gt;&lt;p&gt;&lt;b&gt;title&lt;/b&gt;: TEST PURPOSES ONLY - skilarence Vulcan ePI&lt;/p&gt;&lt;p&gt;&lt;b&gt;confidentiality&lt;/b&gt;: unrestricted&lt;/p&gt;&lt;/div&gt;&quot;
  ];
  <a href="http://build.fhir.org/composition.html#Composition.status">fhir:Composition.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;final&quot;];
  <a href="http://build.fhir.org/composition.html#Composition.type">fhir:Composition.type</a> [
     <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
       <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
       <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538&quot; ]     ];
     <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Package Leaflet&quot; ]
  ];
  <a href="http://build.fhir.org/composition.html#Composition.date">fhir:Composition.date</a> [ <a href="http://build.fhir.org/datatypes.html#dateTime">fhir:value</a> &quot;2015-02-07T13:28:17Z&quot;^^xsd:dateTime];
  <a href="http://build.fhir.org/composition.html#Composition.author">fhir:Composition.author</a> [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
     <a href="http://build.fhir.org/references.html#Reference#Reference.reference">fhir:Reference.reference</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Organization/cfsb1639003145277&quot; ]
  ];
  <a href="http://build.fhir.org/composition.html#Composition.title">fhir:Composition.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;TEST PURPOSES ONLY - skilarence Vulcan ePI&quot;];
  <a href="http://build.fhir.org/composition.html#Composition.confidentiality">fhir:Composition.confidentiality</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;unrestricted&quot;];
  <a href="http://build.fhir.org/composition.html#Composition.section">fhir:Composition.section</a> [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
     <a href="http://build.fhir.org/composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. Package Leaflet&quot; ];
     <a href="http://build.fhir.org/composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538&quot; ]       ];
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. PACKAGE LEAFLET&quot; ]     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;additional&quot; ];
       fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p&gt;&lt;b&gt;Skilarence 30 mg gastro-resistant tablets&lt;/b&gt;&lt;/p&gt;&lt;p&gt;dimethyl fumarate&lt;/p&gt;&lt;p&gt;&lt;b&gt;Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Keep this leaflet. You may need to read it again.&lt;/li&gt;&lt;li&gt;If you have any further questions, ask your doctor or pharmacist.&lt;/li&gt;&lt;li&gt;This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.&lt;/li&gt;&lt;li&gt;If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&quot;     ]
  ], [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
     <a href="http://build.fhir.org/composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;What is in this leaflet&quot; ];
     <a href="http://build.fhir.org/composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538-0&quot; ]       ];
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. PACKAGE LEAFLET&quot; ]     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;additional&quot; ];
       fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;ol&gt;&lt;li&gt;What Skilarence is and what it is used for&lt;/li&gt;&lt;li&gt;What you need to know before you take Skilarence&lt;/li&gt;&lt;li&gt;How to take Skilarence&lt;/li&gt;&lt;li&gt;Possible side effects&lt;/li&gt;&lt;li&gt;How to store Skilarence&lt;/li&gt;&lt;li&gt;Contents of the pack and other information&lt;/li&gt;&lt;/ol&gt;&lt;/div&gt;&quot;     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.entry">fhir:Composition.section.entry</a> [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
       <a href="http://build.fhir.org/references.html#Reference#Reference.reference">fhir:Reference.reference</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;RegulatedAuthorization/cfsb1639761980721&quot; ]     ]
  ], [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
     <a href="http://build.fhir.org/composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1. What Skilarence is and what it is used for&quot; ];
     <a href="http://build.fhir.org/composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538-1&quot; ]       ];
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. PACKAGE LEAFLET&quot; ]     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;additional&quot; ];
       fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p&gt;&lt;b&gt;What Skilarence is&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Skilarence is a medicine that contains the active substance dimethyl fumarate. Dimethyl fumarate works on cells of the immune system (the body's natural defences). It changes the activity of the immune system and reduces the production of substances involved in causing psoriasis.&lt;/p&gt;&lt;p&gt;&lt;b&gt;What Skilarence is used for&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Skilarence tablets are used to treat moderate to severe plaque psoriasis in adults. Psoriasis is a disease causing thickened, inflamed, red areas on the skin, often covered by silvery scales.&lt;/p&gt;&lt;p&gt;Response to Skilarence can be generally seen as early as week 3 and improves over time. Experience with related products containing dimethyl fumarate shows treatment benefit for at least up to 24 months.&lt;/p&gt;&lt;/div&gt;&quot;     ]
  ], [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 3;
     <a href="http://build.fhir.org/composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;2. What you need to know before you take Skilarence&quot; ];
     <a href="http://build.fhir.org/composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538-2&quot; ]       ];
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. PACKAGE LEAFLET&quot; ]     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;additional&quot; ];
       fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p&gt;&lt;b&gt;Do not take Skilarence&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;if you are allergic to dimethyl fumarate or any of the other ingredients of this medicine (listed in section 6)&lt;/li&gt;&lt;li&gt;if you have severe problems with your stomach or intestines&lt;/li&gt;&lt;li&gt;if you have severe liver or kidney problems&lt;/li&gt;&lt;li&gt;if you are pregnant or breast-feeding&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Warnings and precautions&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Talk to your doctor or pharmacist before taking Skilarence.&lt;/p&gt;&lt;p&gt;&lt;u&gt;Monitoring&lt;/u&gt;&lt;/p&gt;&lt;p&gt;Skilarence may cause problems with your blood, liver or kidneys. You will have blood and urine tests before treatment and then regularly during your treatment to make sure that you are not getting these complications and can continue to take this medicine. Depending on the results of these blood and urine tests, your doctor may reduce your dose of Skilarence or stop treatment.&lt;/p&gt;&lt;p&gt;&lt;u&gt;Infections&lt;/u&gt;&lt;/p&gt;&lt;p&gt;White blood cells help your body to fight infections. Skilarence may reduce the number of your white blood cells. Talk to your doctor if you think you may have an infection. Symptoms include fever, pain, aching muscles, headache, loss of appetite and a general feeling of weakness. If you have a serious infection, either before starting treatment with Skilarence or during treatment, your doctor may advise you not to take Skilarence until the infection has resolved.&lt;/p&gt;&lt;p&gt;&lt;u&gt;Gastrointestinal disorders&lt;/u&gt;&lt;/p&gt;&lt;p&gt;Tell your doctor if you have or have had problems with your stomach or intestines. Your doctor will advise you on what care you need to take during Skilarence treatment.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Children and adolescents&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Children and adolescents below the age of 18 years should not take this medicine because it has not been studied in this age group.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Other medicines and Skilarence&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.&lt;/p&gt;&lt;p&gt;In particular, tell your doctor if you are taking the following:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;b&gt;Dimethyl fumarate or other fumarates.&lt;/b&gt; The active ingredient in Skilarence, dimethyl fumarate, is also used in other medicines such as tablets, ointments and baths. You must avoid using other products that contain fumarates to prevent taking too much.&lt;/li&gt;&lt;li&gt;&lt;b&gt;Other medicines used to treat psoriasis,&lt;/b&gt; such as methotrexate, retinoids, psoralens, ciclosporin, or other immunosuppressants or cytostatics (medicines that affect the immune system). Taking these medicines with Skilarence could increase the risk of side effects on your immune system.&lt;/li&gt;&lt;li&gt;&lt;b&gt;Other medicines that can affect your kidney function,&lt;/b&gt; such as methotrexate or ciclosporin (used to treat psoriasis), aminoglycosides (used to treat infections), diuretics (which increase urine), nonsteroidal anti-inflammatory drugs (used to treat pain) or lithium (used for bipolar disease and depression). These medicines taken together with Skilarence could increase the risk of side effects on your kidneys.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;If you get severe or prolonged diarrhoea with Skilarence, other medicines may not work as well as they should. Talk to your doctor if you have bad diarrhoea and are concerned that other medicines you are taking might not work. In particular, if you are taking a contraceptive medicine (the pill), the effect may be reduced and you may need to use other barrier methods to prevent pregnancy. See the instructions in the patient leaflet of the contraceptive you are taking.&lt;/p&gt;&lt;p&gt;If you need a vaccination, talk to your doctor. Certain types of vaccines (live vaccines) may cause infection if used during treatment with Skilarence. Your doctor can advise you what would be best.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Skilarence with alcohol&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Avoid strong alcoholic drinks (more than 50 ml of spirits containing more than 30% alcohol by volume) during treatment with Skilarence, as alcohol can interact with this medicine. This could cause stomach and intestinal problems.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Pregnancy and breast-feeding&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Do not take Skilarence if you are pregnant or trying to become pregnant, as Skilarence may harm your baby. Use effective methods of contraception to avoid becoming pregnant during treatment with Skilarence (see also “Other medicines and Skilarence” above). Do not breast-feed during treatment with Skilarence.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Driving and using machines&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Skilarence may have a minor influence on the ability to drive and use machines. You may feel dizzy or tired after taking Skilarence. If you are affected, be careful when driving or using machines.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Skilarence contains lactose&lt;/b&gt;&lt;/p&gt;&lt;p&gt;If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Skilarence contains sodium&lt;/b&gt;&lt;/p&gt;&lt;p&gt;This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium- free’.&lt;/p&gt;&lt;p&gt;Do not take Skilarence&lt;/p&gt;&lt;ul&gt;&lt;li&gt;if you are allergic to dimethyl fumarate or any of the other ingredients of this medicine (listed in section 6)&lt;/li&gt;&lt;li&gt;if you have severe problems with your stomach or intestines&lt;/li&gt;&lt;li&gt;if you have severe liver or kidney problems&lt;/li&gt;&lt;li&gt;if you are pregnant or breast-feeding&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Warnings and precautions&lt;/p&gt;&lt;p&gt;Skilarence may cause problems with your blood, liver or kidneys. You will have blood and urine tests before treatment and then regularly during your treatment to make sure that you are not getting these complications and can continue to take this medicine. Depending on the results of these blood and urine tests, your doctor may reduce your dose of Skilarence or stop treatment.&lt;/p&gt;&lt;p&gt;Infections&lt;/p&gt;&lt;p&gt;White blood cells help your body to fight infections. Skilarence may reduce the number of your white blood cells. Talk to your doctor if you think you may have an infection. Symptoms include fever, pain, aching muscles, headache, loss of appetite and a general feeling of weakness. If you have a serious infection, either before starting treatment with Skilarence or during treatment, your doctor may advise you not to take Skilarence until the infection has resolved.&lt;/p&gt;&lt;p&gt;Gastrointestinal disorders&lt;/p&gt;&lt;p&gt;Tell your doctor if you have or have had problems with your stomach or intestines. Your doctor will advise you on what care you need to take during Skilarence treatment.&lt;/p&gt;&lt;p&gt;Children and adolescents&lt;/p&gt;&lt;p&gt;Children and adolescents below the age of 18 years should not take this medicine because it has not been studied in this age group.&lt;/p&gt;&lt;p&gt;Other medicines and Skilarence&lt;/p&gt;&lt;p&gt;Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.&lt;/p&gt;&lt;p&gt;In particular, tell your doctor if you are taking the following:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;b&gt;Dimethyl fumarate or other fumarates.&lt;/b&gt; The active ingredient in Skilarence, dimethyl fumarate, is also used in other medicines such as tablets, ointments and baths. You must avoid using other products that contain fumarates to prevent taking too much.&lt;/li&gt;&lt;li&gt;&lt;b&gt;Other medicines used to treat psoriasis,&lt;/b&gt; such as methotrexate, retinoids, psoralens, ciclosporin, or other immunosuppressants or cytostatics (medicines that affect the immune system). Taking these medicines with Skilarence could increase the risk of side effects on your immune system.&lt;/li&gt;&lt;li&gt;&lt;b&gt;Other medicines that can affect your kidney function,&lt;/b&gt; such as methotrexate or ciclosporin (used to treat psoriasis), aminoglycosides (used to treat infections), diuretics (which increase urine), nonsteroidal anti-inflammatory drugs (used to treat pain) or lithium (used for bipolar disease and depression). These medicines taken together with Skilarence could increase the risk of side effects on your kidneys.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;If you get severe or prolonged diarrhoea with Skilarence, other medicines may not work as well as they should. Talk to your doctor if you have bad diarrhoea and are concerned that other medicines you are taking might not work. In particular, if you are taking a contraceptive medicine (the pill), the effect may be reduced and you may need to use other barrier methods to prevent pregnancy. See the instructions in the patient leaflet of the contraceptive you are taking.&lt;/p&gt;&lt;p&gt;If you need a vaccination, talk to your doctor. Certain types of vaccines (live vaccines) may cause infection if used during treatment with Skilarence. Your doctor can advise you what would be best.&lt;/p&gt;&lt;p&gt;Skilarence with alcohol&lt;/p&gt;&lt;p&gt;Avoid strong alcoholic drinks (more than 50 ml of spirits containing more than 30% alcohol by volume) during treatment with Skilarence, as alcohol can interact with this medicine. This could cause stomach and intestinal problems.&lt;/p&gt;&lt;p&gt;Pregnancy and breast-feeding&lt;/p&gt;&lt;p&gt;Do not take Skilarence if you are pregnant or trying to become pregnant, as Skilarence may harm your baby. Use effective methods of contraception to avoid becoming pregnant during treatment with Skilarence (see also “Other medicines and Skilarence” above). Do not breast-feed during treatment with Skilarence.&lt;/p&gt;&lt;p&gt;Driving and using machines&lt;/p&gt;&lt;p&gt;Skilarence may have a minor influence on the ability to drive and use machines. You may feel dizzy or tired after taking Skilarence. If you are affected, be careful when driving or using machines.&lt;/p&gt;&lt;p&gt;Skilarence contains lactose&lt;/p&gt;&lt;p&gt;If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.&lt;/p&gt;&lt;p&gt;Skilarence contains sodium&lt;/p&gt;&lt;p&gt;This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium- free’.&lt;/p&gt;&lt;/div&gt;&quot;     ]
  ], [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 4;
     <a href="http://build.fhir.org/composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;3. How to take Skilarence&quot; ];
     <a href="http://build.fhir.org/composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538-3&quot; ]       ];
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. PACKAGE LEAFLET&quot; ]     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;additional&quot; ];
       fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p&gt;Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Dose&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Your doctor will start your treatment with a low dose (using 30 mg Skilarence tablets). This helps to reduce stomach problems and other side effects. Your dose will be increased every week as shown in the table below (switching to 120 mg Skilarence tablets from week 4 onwards).&lt;/p&gt;&lt;p&gt;Your doctor will check how well your condition is improving after you start taking Skilarence and will check for side effects. If you have severe side effects after an increase in dose, your doctor may recommend that you temporarily go back to the last dose. If the side effects are not troublesome, your dose will be increased until your condition is well controlled. You may not need the maximum dose of 720 mg per day. After your condition has improved sufficiently, your doctor will consider how to gradually reduce the daily dose of Skilarence to what you need to maintain your improvement.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Method of administration&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Swallow Skilarence tablets whole with liquid. Take your tablets during or immediately after a meal. Do not crush, break, dissolve or chew your tablets, as they have a special coating to help prevent irritation of your stomach.&lt;/p&gt;&lt;p&gt;&lt;b&gt;If you take more Skilarence than you should&lt;/b&gt;&lt;/p&gt;&lt;p&gt;If you think you have taken too many Skilarence tablets, talk to your doctor or pharmacist.&lt;/p&gt;&lt;p&gt;&lt;b&gt;If you forget to take Skilarence&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Do not take a double dose to make up for a forgotten dose. Take the next dose at the usual time and continue taking the medicine exactly as described in this leaflet or exactly as agreed with your doctor. Please ask your doctor or pharmacist if you are not sure.&lt;/p&gt;&lt;p&gt;If you have any further questions on the use of this medicine, ask your doctor or pharmacist.&lt;/p&gt;&lt;/div&gt;&quot;     ]
  ], [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 5;
     <a href="http://build.fhir.org/composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;4. Possible side effects&quot; ];
     <a href="http://build.fhir.org/composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538-4&quot; ]       ];
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. PACKAGE LEAFLET&quot; ]     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;additional&quot; ];
       fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p&gt;Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of these side effects, such as reddening of the face or body (flushing), diarrhoea, stomach problems and nausea usually improve as you continue treatment.&lt;/p&gt;&lt;p&gt;The most serious side effects that may occur with Skilarence are allergic or hypersensitivity reactions; kidney failure or a kidney disease called Fanconi syndrome; or a severe brain infection called progressive multifocal leukoencephalopathy (PML). It is not known how commonly they occur. For symptoms see below.&lt;/p&gt;&lt;p&gt;&lt;u&gt;Allergic or hypersensitivity reactions&lt;/u&gt;&lt;/p&gt;&lt;p&gt;Allergic or hypersensitivity reactions are rare but may be very serious. Reddening of the face or body (flushing) is a very common side effect which may affect more than 1 in 10 people. However, if you become flushed and get any of the following signs:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;wheezing, difficulty breathing or shortness of breath,&lt;/li&gt;&lt;li&gt;swelling of the face, lips, mouth or tongue&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;stop taking Skilarence and call a doctor straight away.&lt;/p&gt;&lt;p&gt;&lt;u&gt;Brain infection called PML&lt;/u&gt;&lt;/p&gt;&lt;p&gt;Progressive multifocal leukoencephalopathy (PML) is a rare but serious brain infection that can lead to severe disability or death. If you notice new or worsening weakness on one side of the body; clumsiness; changes in vision, thinking or memory; confusion; or personality changes lasting several days, stop taking Skilarence and talk to your doctor straight away.&lt;/p&gt;&lt;p&gt;&lt;u&gt;Fanconi syndrome&lt;/u&gt;&lt;/p&gt;&lt;p&gt;Fanconi syndrome is a rare but serious kidney disorder which may occur with Skilarence. If you notice you are passing more urine, are more thirsty and drinking more than normal, your muscles seem weaker, you break a bone, or just have aches and pains, talk to your doctor as soon as possible so that this can be investigated further.&lt;/p&gt;&lt;p&gt;Talk to your doctor if you get any of the following side effects.&lt;/p&gt;&lt;p&gt;Very common side effects (may affect more than 1 in 10 people):&lt;/p&gt;&lt;ul&gt;&lt;li&gt;decrease in white blood cells called lymphocytes (lymphopenia)&lt;/li&gt;&lt;li&gt;decrease in all white blood cells (leukopenia)&lt;/li&gt;&lt;li&gt;reddening of the face or body (flushing)&lt;/li&gt;&lt;li&gt;diarrhoea&lt;/li&gt;&lt;li&gt;bloating, stomach pain or stomach cramps&lt;/li&gt;&lt;li&gt;feeling sick (nausea)&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Common side effects (may affect up to 1 in 10 people):&lt;/p&gt;&lt;ul&gt;&lt;li&gt;increase in all white blood cells (leukocytosis)&lt;/li&gt;&lt;li&gt;increase in specific white blood cells called eosinophils&lt;/li&gt;&lt;li&gt;increase in certain enzymes in the blood (used for checking the health of your liver)&lt;/li&gt;&lt;li&gt;being sick&lt;/li&gt;&lt;li&gt;constipation&lt;/li&gt;&lt;li&gt;gas (flatulence), stomach discomfort, indigestion&lt;/li&gt;&lt;li&gt;decreased appetite&lt;/li&gt;&lt;li&gt;headache&lt;/li&gt;&lt;li&gt;feeling tired&lt;/li&gt;&lt;li&gt;weakness&lt;/li&gt;&lt;li&gt;feeling hot&lt;/li&gt;&lt;li&gt;abnormal sensations of the skin, such as itching, burning, stinging, tickling or tingling&lt;/li&gt;&lt;li&gt;pink or red blotches on the skin (erythema)&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Uncommon side effects (may affect up to 1 in 100 people):&lt;/p&gt;&lt;ul&gt;&lt;li&gt;dizziness&lt;/li&gt;&lt;li&gt;excess protein in the urine (proteinuria)&lt;/li&gt;&lt;li&gt;increase in serum creatinine (a substance in the blood used for measuring how well your kidneys are working)&lt;/li&gt;&lt;li&gt;allergic skin reaction&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Very rare side effects (may affect up to 1 in 10,000 people):&lt;/p&gt;&lt;ul&gt;&lt;li&gt;acute lymphatic leukaemia (a type of blood cancer)&lt;/li&gt;&lt;li&gt;tddecrease in all types of blood cells (pancytopenia)&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Frequency not known (frequency cannot be estimated from the available data):&lt;/p&gt;&lt;ul&gt;&lt;li&gt;shingles&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;Reporting of side effects&lt;/b&gt;&lt;/p&gt;&lt;p&gt;If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.&lt;/p&gt;&lt;/div&gt;&quot;     ]
  ], [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 6;
     <a href="http://build.fhir.org/composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;5. How to store Skilarence&quot; ];
     <a href="http://build.fhir.org/composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538-5&quot; ]       ];
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. PACKAGE LEAFLET&quot; ]     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;additional&quot; ];
       fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p&gt;Keep this medicine out of the sight and reach of children.&lt;/p&gt;&lt;p&gt;Do not use this medicine after the expiry date which is stated on the carton and the blister after “EXP”. The expiry date refers to the last day of that month.&lt;/p&gt;&lt;p&gt;This medicine does not require any special storage conditions.&lt;/p&gt;&lt;p&gt;Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.&lt;/p&gt;&lt;/div&gt;&quot;     ]
  ], [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 7;
     <a href="http://build.fhir.org/composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;6. Contents of the pack and other information&quot; ];
     <a href="http://build.fhir.org/composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;https://spor.ema.europa.eu/&quot; ];
         <a href="http://build.fhir.org/datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;100000155538-6&quot; ]       ];
       <a href="http://build.fhir.org/datatypes.html#CodeableConcept#CodeableConcept.text">fhir:CodeableConcept.text</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;B. PACKAGE LEAFLET&quot; ]     ];
     <a href="http://build.fhir.org/composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;additional&quot; ];
       fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p&gt;&lt;b&gt;What Skilarence 30 mg contains&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;the active substance is dimethyl fumarate. One tablet contains 30 mg dimethyl fumarate.&lt;/li&gt;&lt;li&gt;the other ingredients are: lactose monohydrate, cellulose microcrystalline, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, methacrylic acid-ethyl acrylate copolymer (1:1), talc, triethyl citrate, titanium dioxide (E171) and simethicone.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;b&gt;What Skilarence 30 mg looks like and contents of the pack&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Skilarence 30 mg is a white, round tablet with a diameter of approximately 6.8 mm. Skilarence 30 mg is available in packs containing 42, 70 and 210 gastro-resistant tablets. Not all pack sizes may be marketed. The tablets are packed in PVC/PVDC-aluminium blisters.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Marketing Authorisation Holder and Manufacturer&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Marketing Authorisation Holder&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall, S.A.&lt;/p&gt;&lt;p&gt;Ronda General Mitre, 151 E-08022 Barcelona&lt;/p&gt;&lt;p&gt;Spain&lt;/p&gt;&lt;p&gt;Tel. +34 93 291 30 00&lt;/p&gt;&lt;p&gt;&lt;b&gt;Manufacturer&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Industrias Farmacéuticas Almirall, S.A. Ctra. de Martorell 41-61&lt;/p&gt;&lt;p&gt;E-08740 Sant Andreu de la Barca, Barcelona Spain&lt;/p&gt;&lt;p&gt;For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:&lt;/p&gt;&lt;p&gt;&lt;b&gt;België/Belgique/Belgien/ Luxembourg/Luxemburg&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall N.V., Tél/Tel: +32 (0)2 771 86 37&lt;/p&gt;&lt;p&gt;&lt;b&gt;България/ Česká republika/ Eesti/ España/ Hrvatska/ Κύπρος/ Latvija/ Lietuva/ Magyarország/ Malta/ România/ Slovenija/ Slovenská republika&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall, S.A., Teл./ Tel/ Τηλ: +34 93 291 30 00&lt;/p&gt;&lt;p&gt;Tel (Česká republika / Slovenská republika): +420 220 990 139&lt;/p&gt;&lt;p&gt;&lt;b&gt;Danmark/ Norge/ Suomi/Finland/ Sverige Almirall ApS, Tlf/ Puh/Tel: +45 70 25 75 75&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Deutschland&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall Hermal GmbH, Tel.: +49 (0)40 72704-0&lt;/p&gt;&lt;p&gt;&lt;b&gt;Ελλάδα&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Galenica A.E., Tηλ: +30 210 52 81 700&lt;/p&gt;&lt;p&gt;&lt;b&gt;France&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall SAS, Tél.: +33(0)1 46 46 19 20&lt;/p&gt;&lt;p&gt;&lt;b&gt;Ireland/ United Kingdom (Northern Ireland)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall, S.A., Tel: +353 (0) 1431 9836&lt;/p&gt;&lt;p&gt;&lt;b&gt;Ísland&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Vistor hf., Sími: +354 535 70 00&lt;/p&gt;&lt;p&gt;&lt;b&gt;Italia&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall SpA, Tel.: +39 02 346181&lt;/p&gt;&lt;p&gt;&lt;b&gt;Nederland&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall B.V., Tel: +31 (0)30 799 1155&lt;/p&gt;&lt;p&gt;&lt;b&gt;Österreich&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall GmbH, Tel.: +43 (0)1/595 39 60&lt;/p&gt;&lt;p&gt;&lt;b&gt;Polska&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall Sp.z o. o., Tel.: +48 22 330 02 57&lt;/p&gt;&lt;p&gt;&lt;b&gt;Portugal&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Almirall - Produtos Farmacêuticos, Lda., Tel.: +351 21 415 57 50&lt;/p&gt;&lt;p&gt;This leaflet was last revised in .&lt;/p&gt;&lt;p&gt;&lt;b&gt;Other sources of information&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.&lt;/p&gt;&lt;/div&gt;&quot;     ]
  ].

# - ontology header ------------------------------------------------------------

 a owl:Ontology;
  owl:imports fhir:fhir.ttl.

</code></pre>



  <!-- insert notes if present -->
  



</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript">
    $(document).ready(function(){
      if(window.location.hash != "") {
          $('a[href="' + window.location.hash + '"]').click()
      }
    });
  </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div class="inner-wrapper">
        <p>
          IG &#169; 2021+ <a style="color:var(--footer-hyperlink-text-color)" href="https://www.gravitatehealth.eu/"></a>.  Package hl7.eu.fhir.gh#0.1.0 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://build.fhir.org/">FHIR 5.0.0-snapshot1</a>. Generated <span title="Tue, Jan 11, 2022 15:19+0000">2022-01-11</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)"></span>
            <div style="color: #33333" >
	Links: <a style="color: #81BEF7"
 		href="toc.html">Table of Contents</a> |
	<a style="color: #81BEF7"
 		href="qa.html">QA Report</a>
	<!--
                 <a style="color: #81BEF7" target="_blank" href="http://hl7.eu/fhir/ig/gravitate-health/history.html">Version History <img alt="external" style="vertical-align: baseline" src="external.png"/></a></a> |
-->
	<a style="color: #81BEF7"
 		rel="license"
 		href="http://build.fhir.org/license.html">
		<img style="border-style: none;"
   			alt="CC0"
   			src="cc0.png"/>
	</a>
	<!--<a style="color: #81BEF7" href="todo.html">Search</a> | -->
	<!--
                 <a style="color: #81BEF7" target="_blank" href="mailto:mail@hl7belgium.org">Propose a change<img alt="external" style="vertical-align: baseline" src="external.png"/></a>
-->
	<!--				 
<br/>				 
				 <a style="color: #81BEF7" rel="eufunded" href="https://europa.eu"><img style="border-style: none;" alt="EU" src="assets/images/en_horizontal_cef_logo.png" width="250"/></a>
	-->
	<div id=container width=100% style="display:block;" >
		<div style="float: left; padding-top: 17px; padding-bottom: 17px;" >The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.<br/>
			This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.</div>
		<div style="float: right; width: 69px; vertical-align:middle; text-align:center; padding-top: 17px; padding-bottom: 17px;">
			<img height="41"
   				alt="a EU funded project"
   				src="assets/images/eu.png"/>
		</div>
	</div>
	<div>
	</div>
</div>
          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->
  
  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script>anchors.options.visible = 'hover'
anchors.add()</script>
  
<!-- feedback form - Google forms -->
<!-- v0.1, 2021-01-09 -->



<!-- / feedback form  -->

  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

